At a glance
ClinicalIndex Comparison RecordN/ACompleted· 107 enrolled
Drug / intervention
pharmacological study +1 moreother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Pharmacokinetics of Daunomycin in Children
In Brief
A clinical study evaluating pharmacological study and dual x-ray absorptimetry for Unspecified Childhood Solid Tumor, Protocol Specific. Completed, enrolled 107 participants across 60 sites in 4 countries.
Detailed Summary
This laboratory study is looking at the pharmacokinetics of daunorubicin in young patients with cancer. Collecting and storing samples of blood from patients with cancer to study in the laboratory may help doctors learn more about how patients respond to treatment with certain chemotherapy drugs.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesAustralia, Canada, Switzerland, United States
CollaboratorsNational Cancer Institute (NCI)
Timeline
N/ACompletedFinished
200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartJan 2007
First PostedMay 2008
Primary CompletionJul 2011
Study CompletionMar 2020
TodayJul 2026
First PostedMay 7, 2008
Enrollment StartJan 1, 2007
Primary CompletionJul 1, 2011
Study CompletionMar 31, 2020
TodayJul 2, 2026
Enrollment to primary: 4.5 yearsPosted 18.2 years ago
Interventions
pharmacological studyother
pharmacological studies
dual x-ray absorptimetryprocedure